Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic kidney disease].

Hans-Joachim Anders1

  • 1Nephrologisches Zentrum, Medizinische Poliklinik, Klinikum der Universität München-Innenstadt, München. hjanders@med.uni-muenchen.de

Medizinische Klinik (Munich, Germany : 1983)
|December 6, 2005
PubMed
Summary

This review covers updated guidelines for managing chronic kidney disease (CKD) complications like hypertension and anemia. It highlights new treatments and emphasizes controlling risk factors to reduce cardiovascular mortality in renal patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NDT and MARKUS@HOMe Partnership.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

CCR5 and CD74 are potential therapeutic targets for necroinflammation in preclinical cholesterol crystal embolism.

Science translational medicine·2026
Same author

A post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis.

Kidney international·2026
Same author

Platelet Cyclophilin D Drives Cholesterol Crystal Embolism-Related Acute Kidney Injury and Kidney Infarction.

Journal of the American Society of Nephrology : JASN·2026
Same author

Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.

Biochemical pharmacology·2026
Same author

Active lupus nephritis is an orphan disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Area of Science:

  • Nephrology
  • Internal Medicine
  • Cardiology

Background:

  • Chronic kidney disease (CKD) management requires early diagnosis, preventing progression, and treating complications.
  • Key complications include arterial hypertension, proteinuria, secondary hyperparathyroidism, metabolic acidosis, and renal anemia.
  • High cardiovascular mortality remains a significant challenge in renal patients.

Purpose of the Study:

  • To provide an overview of new treatment guidelines for patients with chronic kidney disease.
  • To incorporate recent data from multicenter trials into clinical practice recommendations.
  • To address the management of common CKD complications and reduce cardiovascular risk.

Main Methods:

  • Review of recent multicenter trials and updated treatment guidelines.
  • Synthesis of current evidence for managing hypertension, proteinuria, and other CKD complications.
  • Analysis of new therapeutic options and their impact on patient outcomes.

Main Results:

  • New data have led to significant changes in existing treatment guidelines for CKD.
  • Novel therapeutic agents are now available for managing CKD and its complications.
  • Emphasis on regular assessment and achieving target levels for key parameters is crucial.

Conclusions:

  • Updated guidelines offer improved strategies for managing chronic kidney disease.
  • New treatments and approaches aim to mitigate cardiovascular mortality in renal patients.
  • Proactive management of CKD complications is essential for better patient prognosis.

Related Experiment Videos